Changes to policy on drug good manufacturing practices and DEL enforcement (POL-0004)

Description

Health Canada has made changes to the policy on drug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement (POL-0004). This policy supports the consistent and transparent application of compliance and enforcement actions under Canada’s GMP and DEL regulatory schemes.

Resources

Name Format Description Link
21 https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/drug-establishment-licensing-bulletin/changes-policy-good-manufacturing-practices.html
21 https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/conformite-application-loi/licences-etablissement/bulletin-licences-etablissement-pharmaceutiques/modifications-politique-bonnes-pratiques-fabrication.html

Tags

Topics

Categories